BIOMET UK LTD.

Manufacturer adverse-event records for BIOMET UK LTD. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2005–2026 · mid-book · typical Death-code · injury-heavy

Injury-mix signature

BIOMET UK LTD. leans injury-heavy in event_type mix

Injury-coded event_type share is 89.1% (injury-heavy tercile) beside 0.56% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for BIOMET UK LTD.

The standout signal for BIOMET UK LTD. is Injury-mix: 89.1% Injury-coded (injury-heavy) beside 0.56% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for BIOMET UK LTD.. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 8,887 (89.1% of event_type total). Peak single-year volume reaches 1,275 reports across 22 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

9,976
Total Reports
56
Event-type Death
8,887
Injury Reports
20
Device Types

Event Types

Injury 8,887 (89.1%)
Malfunction 1,029 (10.3%)
Death 56 (0.6%)
3 (0.0%)
Other 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Hospitalization 6,621 (38.1%)
R 6,407 (36.9%)
Required Intervention 1,282 (7.4%)
1,085 (6.2%)
H 869 (5.0%)
Other 855 (4.9%)
O 95 (0.5%)
Death 65 (0.4%)
S 36 (0.2%)
Life Threatening 21 (0.1%)
Disability 19 (0.1%)
Congenital Anomaly 11 (0.1%)
L 4 (0.0%)

Yearly Trend

05
2005: 5
06
2006: 1
07
2007: 12
08
2008: 26
09
2009: 56
10
2010: 122
11
2011: 211
12
2012: 375
13
2013: 340
14
2014: 396
15
2015: 604
16
2016: 941
17
2017: 1,234
18
2018: 1,275
19
2019: 937
20
2020: 550
21
2021: 530
22
2022: 485
23
2023: 430
24
2024: 494
25
2025: 685
26
2026: 267